Wire flash
HealthFDA-approved Setmelanotide offers breakthrough relief for Spokane boy with rare hunger condition
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
A Spokane boy suffering from a rare condition causing constant hunger due to brain damage has found relief through a breakthrough treatment in Seattle. The condition, hypothalamic obesity, results from brain injury or tumors and leads to uncontrollable appetite. The drug Setmelanotide, recently approved by the FDA, has shown significant results in clinical trials, reducing BMI and alleviating symptoms. The boy's family reports he is now 'back to living life' after the treatment, which targets the underlying mechanism of the condition. This development offers hope for patients with acquired hypothalamic obesity, a previously difficult-to-treat disorder.
Source report
A medical breakthrough in Seattle is providing relief for a Spokane boy suffering from a rare condition that causes constant, unrelenting hunger.
Key Developments
- Setmelanotide cuts BMI in hypothalamic obesity trial — the limbic
- FDA approves new therapy for obesity caused by brain injury — NR Times
- ‘Back to living life’: Spokane boy finds treatment for constant hunger caused by brain damage — The Spokesman-Review
- Setmelanotide in Patients With Acquired Hypothalamic Obesity From Brain Tumors — The ASCO Post
Overview
The U.S. Food and Drug Administration (FDA) has approved a new therapy targeting obesity resulting from brain injury. The treatment, setmelanotide, has shown promise in clinical trials by reducing body mass index (BMI) in patients with hypothalamic obesity.
For one Spokane boy, the breakthrough has been life-changing. After suffering brain damage that led to a rare hunger condition, he has found relief through the new treatment, allowing him to return to a more normal life.
The therapy addresses acquired hypothalamic obesity, a condition that can develop after brain tumors or other injuries to the hypothalamus, the region of the brain responsible for regulating appetite and metabolism.
Source
Top stories - Google NewsWestern
Part of this Story
Seattle breakthrough offers Spokane boy relief from rare hunger condition